Xu JZ, Garrett ME, Soldano KL, et al. Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease. Am J Hematol. 2018;93(12):1451-1460. doi:10.1002/ajh.25263.

Kahn T, Bosch J, Levitt MF, Goldstein MH. Effect of sodium nitrate loading on electrolyte transport by the renal tubule. Am J Physiol. 1975;229(3):746-53.

Christov M, Clark AR, Corbin B, et al. Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalities. JCI Insight. 2018;3(4). doi:10.1172/jci.insight.95091.

Raffield LM, Ulirsch JC, Naik RP, et al. Common α-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and disease. PLoS Genet. 2018;14(3):e1007293. doi:10.1371/journal.pgen.1007293.

Naik RP, Derebail VK, Grams ME, et al. Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans. JAMA. 2014;312(20):2115-25. doi:10.1001/jama.2014.15063.

Rhee EP, Clish CB, Pierce KA, Saad A, Lerman LO, Textor SC. Metabolomics of renal venous plasma from individuals with unilateral renal artery stenosis and essential hypertension. J Hypertens. 2015;33(4):836-42. doi:10.1097/HJH.0000000000000470.

Gorski M, Tin A, Garnaas M, et al. Genome-wide association study of kidney function decline in individuals of European descent. Kidney Int. 2015;87(5):1017-29. doi:10.1038/ki.2014.361.